TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
CompletedN/A

Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease

The purpose of this study is to determine the impact of sleep and breathing problems during sleep on memory, attention, and general well being (quality of life) in people with Parkinson Disease.

Miami, Florida, United StatesView details
Not yet recruitingN/A

Developing Immersive Gamification Technology Systems For The Rehabilitation Management Of Adults With Parkinson's Disease (Phase 1 Trial)

This clinical trial aims to develop and test a prototype immersive gamification technology system (ImGTS) among healthy volunteers and to determine its acceptability, safety, and usability in a healthy population. The main question it aims

Manila, National Capital Region, PhilippinesView details
Completed

Development of a Face Valid Executive Functioning Task

The purpose of this study is to develop a task to measure executive thinking skills that can be performed in a laboratory setting, but has clear parallels to the thinking demands of real life situations, and can be administered to patients

St Louis, Missouri, United StatesView details
CompletedN/A

A Study to Evaluate Temporary Blood Brain Barrier Disruption in Patients With Parkinson's Disease Dementia

The goal of this prospective, non-randomized, single-arm, feasibility study is to develop data to evaluate the safety and initial efficacy of this treatment (temporary disruption of the BBB) using this ExAblate Model 4000 Type 2 System in p

Móstoles, Madrid, SpainView details
RecruitingN/A

Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease

The purpose of this study is to test a new way to treat Parkinson's disease (PD). Subjects will be implanted with deep brain stimulator (DBS) devices and electrodes placed under the scalp.

San Francisco, California, United StatesView details
CompletedPhase 3

Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease

The purpose of this study is to evaluate the efficacy and safety of two doses of safinamide (50 and 100 mg/day, p.o.), compared to placebo, as add-on therapy in patients with idiopathic Parkinson's disease with motor fluctuations who are cu

Multiple locationsView details
CompletedN/A

Monitoring of Mobility of Parkinson's Patients for Therapeutic Purposes - Clinical Trial

When Parkinson Disease is mild, it responds well to treatment with drugs (L-Dopa and dopamine antagonists). However, as the disease progresses, the effect of the drugs diminishes and lasts for a shorter time (wearing-off), which require phy

Barcelona, Barcelona, Spain+42 moreView details
Completed

Effect of Deep Brain Stimulation on Depression and Quality of Life in Parkinson's Patients

We will evaluate the effect of deep brain stimulation on the depression and quality of life in Parkinson's disease. We aim to compare depression pre-operatively and post-operatively in Parkinson's patients with deep brain stimulation to Par

Nashville, Tennessee, United StatesView details
CompletedPhase 2

A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's Disease

This study involves study participants who have been clinically diagnosed with parkinsonian syndrome or who are at-risk for parkinsonian syndrome, have a family history of parkinsonian syndrome or exposure to environmental toxins potentiall

New Haven, Connecticut, United StatesView details
Unknown

SHMT1 Polymorphism in Parkinson's Disease,

Parkinson Disease (PD) is the most common movement disorder and represents the second most common degenerative disease of the central nervous system . SHMT has been shown to be associated with various diseases.

Asyut, EgyptView details
CompletedN/A

Overcoming Gait Freeze in Parkinson's Disease Using Responsive Cueing

The aim of this pilot/feasibility study is to test if delivering rhythmic vibration cues to the lower legs, specifically in response to gait defects (rather than continuously), can improve walking quality and overcome gait freezing in Parki

Cassington, Oxfordshire, United KingdomView details
UnknownN/A

Digitised Home Based Care for Parkinson's Disease

Parkinson's disease is the world's fastest-growing neurological condition. It is a progressive neurodegenerative disorder that causes a wide range of movement-related (motor) problems (slowness, stiffness, tremor, balance difficulties) and

Plymouth, Devon, United KingdomView details
UnknownN/A

Effect of Adding Computerized Cognitive Training on Balance, Locomotion and Cognition in Parkinson's Disease

BACKGROUND: Postural instability and gait abnormalities are cardinal features in Parkinson's disease (PD). It represents one of the most disabling symptoms in the advanced stages of the disease.

Giza, Giza Governorate, EgyptView details
CompletedPhase 4

Effect of Continuous Apomorphine During the Night on Sleep Disorders in Insomniac Patients With Parkinson's Disease

The purpose of the study is to demonstrate that continuous apomorphine treatment during the night compared with placebo improves sleep quality in insomniac patient with Parkinson's disease.

Clermont-Ferrand, France+8 moreView details
Unknown

Clinical Profile of Parkinson's Disease in Patients With Hepatitis C Infection

There is association between Hepatitis C and Parkinson's Disease as shown from previous studies. The clinical profile and natural history is not fully studied yet.

Multiple locationsView details
Recruiting

Cognitive Testing Online in Parkinson's Disease

This is a feasibility and pilot study. Though large-scale online neurocognitive testing is increasingly being done in psychiatry, there are no such efforts in Parkinson's research.

Montreal, Quebec, CanadaView details
Terminated

Long Term Follow-Up Study for rAAV-GAD Treated Subjects

The purpose of this observational study is the long term follow-up of Parkinson's patients who participated in a clinical trial in which they received AAV-GAD gene transfer into the subthalamic nucleus (STN) region of the brain. Patients wi

Stanford, California, United States+5 moreView details
UnknownN/A

Effect of Speech Therapy in Combination With Non-invasive Brain Stimulation on Speech of Patients With Parkinson's Disease

Up to 90% of patients with Parkinson's disease (PD) have hypokinetic dysarthria (HD) in the early phase of the illness. HD is characterized by a harsh breathy voice quality, reduced variability of pitch and loudness and imprecise articulati

Brno, CzechiaView details
UnknownN/A

Effectiveness of a Program With Aquatic Therapy in Patients With Parkinson's Disease Clinical Trial

The aim of this study is to determine the effect of an aquatic Ai Chi training program on the perception of pain, the maintenance of balance and the functional independence of patients with Parkinson's disease. Fifteen patients diagnosed wi

La Cañada de San Urbano, Almería, SpainView details
CompletedPhase 2

Body Weight Gain, Parkinson, Subthalamic Stimulation

Chronic bilateral subthalamic stimulation leads a spectacular clinical improvement in patients with motor complications. However, the post-operative body weight gain involved may limit the benefits of surgery and induce critical metabolic d

Clermont-Ferrand, FranceView details
Load more trials